Len Bogner: Radient Pharmaceuticals (RPC) update March 31, 2011 Company Update #4 RADIENT PHARMACEUTICALS, INC. (RPC) Leonard Bogner President, Bogner Business Associates LLC March 31, 2011 RPC ($0.46)—AMEX 6-12 Month Target: $3.00-$4.00 Upside Potential: $15.00-$20.00 RATING: SPECULATIVE BUY http://www.cpreports.com/?p=974